The Cervical Cancer Diagnostic Market is estimated to be valued at US$ 5,910.2 million in 2020 and is expected to exhibit a CAGR of 6 % over the forecast period (2021-2027). The diagnosis of cervical cancer relies on a series of advanced laboratory tests, tools, and procedures to evaluate abnormal cells or strains of human papillomavirus (HPV). To thoroughly examine the cervix during colposcopy, it […]
